The closing price of Vaxcyte Inc (NASDAQ: PCVX) was $67.60 for the day, down -0.65% from the previous closing price of $68.04. In other words, the price has decreased by -$0.44 from its previous closing price. On the day, 558361 shares were traded. PCVX stock price reached its highest trading level at $69.04 during the session, while it also had its lowest trading level at $67.50.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our analysis of PCVX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.54 and its Current Ratio is at 7.54. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 07, 2023, initiated with a Buy rating and assigned the stock a target price of $69.
Needham reiterated its Buy rating for the stock on January 03, 2023, while the target price for the stock was revised from $52 to $58.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 01 ’24 when Cowan Elvia sold 11,678 shares for $74.08 per share. The transaction valued at 865,070 led to the insider holds 12,480 shares of the business.
Wassil Jim sold 3,000 shares of PCVX for $221,134 on Mar 01 ’24. The CHIEF OPERATING OFFICER now owns 220,852 shares after completing the transaction at $73.71 per share. On Mar 01 ’24, another insider, PICKERING GRANT, who serves as the CHIEF EXECUTIVE OFFICER of the company, sold 2,616 shares for $73.70 each. As a result, the insider received 192,799 and left with 148,670 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 7.38B and an Enterprise Value of 6.33B.
Stock Price History:
Over the past 52 weeks, PCVX has reached a high of $82.04, while it has fallen to a 52-week low of $34.11. The 50-Day Moving Average of the stock is 70.00, while the 200-Day Moving Average is calculated to be 55.80.
Shares Statistics:
PCVX traded an average of 892.43K shares per day over the past three months and 657.96k shares per day over the past ten days. A total of 108.41M shares are outstanding, with a floating share count of 102.89M. Insiders hold about 5.09% of the company’s shares, while institutions hold 91.67% stake in the company. Shares short for PCVX as of Feb 29, 2024 were 8.46M with a Short Ratio of 9.48, compared to 8.9M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.81% and a Short% of Float of 8.67%.
Earnings Estimates
The firm’s stock currently is rated by 8 analysts. On average, analysts expect EPS of -$1.17 for the current quarter, with a high estimate of -$0.84 and a low estimate of -$1.72, while EPS last year was -$0.7. The consensus estimate for the next quarter is -$1.15, with high estimates of -$0.9 and low estimates of -$1.74.
Analysts are recommending an EPS of between -$3.74 and -$4.75 for the fiscal current year, implying an average EPS of -$4.31. EPS for the following year is -$4.48, with 8 analysts recommending between -$3.02 and -$5.59.
